ticagrelor

Generic: ticagrelor

Labeler: apotex corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ticagrelor
Generic Name ticagrelor
Labeler apotex corp.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 60 mg/1

Manufacturer
Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-4453
Product ID 60505-4453_640ebad3-45ab-9163-21fb-b0f3117cfa82
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208584
Listing Expiration 2026-12-31
Marketing Start 2025-10-31

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605054453
Hyphenated Format 60505-4453

Supplemental Identifiers

RxCUI
1116635 1666332
UPC
0360505445264
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ticagrelor (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number ANDA208584 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (60505-4453-6)
source: ndc

Packages (1)

60505-4453-6 60 TABLET in 1 BOTTLE (60505-4453-6)

Ingredients (1)

ticagrelor (60 mg/1)

Linked Drug Pages (1)

Ticagrelor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "640ebad3-45ab-9163-21fb-b0f3117cfa82", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0360505445264"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["2c59ea45-6113-6e9e-70b5-3b8c8b3d89b6"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (60505-4453-6)", "package_ndc": "60505-4453-6", "marketing_start_date": "20251031"}], "brand_name": "Ticagrelor", "product_id": "60505-4453_640ebad3-45ab-9163-21fb-b0f3117cfa82", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "60505-4453", "generic_name": "Ticagrelor", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208584", "marketing_category": "ANDA", "marketing_start_date": "20251031", "listing_expiration_date": "20261231"}